Hypertension is an important and modifiable risk factor for cardiovascular disease that causes >7 million premature deaths a year worldwide, and that is becoming more prevalent in Western and Asian populations. Population surveys report hypertension to be more frequent among men than women, with sex differences of 4% in the United States, 8% in Canada, and 11% in Western Europe. 1 Although the effects of gonadal hormones on arterial, neural, and renal mechanisms that control blood pressure are considered contributing factors, the reasons for sex differences in hypertension are still not fully understood.
genome-wide association studies have been performed to elucidate the contribution of genetic factors to both conditions. 7, 8 These genetic observations indicate that multiple genetic factors exist that may affect both the blood pressure and serum lipid levels. Some genes involved in lipid metabolism may be involved in the genetic component of the development of hypertension.
Yao is the eleventh largest minority among the 55 minorities in China according to the population size. Bai Ku Yao (white-trouser Yao), an isolated subgroup of the Yao minority, is named so because all of men wear white knee-length knickerbockers. Because of isolation from the other ethnic groups, the special customs and cultures including their clothing, intra-ethnic marriages, diets, and lifestyle are still completely preserved to the present day. In a previous epidemiological survey, we showed that the hypertensive prevalence of the middle-aged and elderly in Bai Ku Yao was higher in males than in females. 9 Thus, we hypothesize that there may exist sex differences in the association of several lipid-related gene polymorphisms and blood pressure variation in this population. Therefore, the aim of the present study was to detect the association of nine single-nucleotide polymorphisms at different lipid-related genes and blood pressure variation beween men and women in the Bai Ku Yao population.
Methods

Subjects.
A total of 682 unrelated normotensives and 670 hypertensives were randomly selected from our previous stratified randomized cluster samples. 9 The ages of the subjects ranged from 15 to 82 years, with an average age of 48.5 ± 14.0 years. All subjects were rural agricultural workers. The participants with a history of chronic illness, including hepatic, renal, thyroid, myocardial infarction, stroke, congestive heart failure, diabetes or fasting blood glucose ≥7.0 mmol/l determined by glucose meter have been excluded. The participants were not taking medications known to affect blood pressure and serum lipid levels (antihypertensive drugs, lipid-lowering drugs such as statins or fibrates, β-blockers, diuretics, hormones, or contraceptive drugs). The present study was approved by the Ethics Committee of the First Affiliated Hospital, Guangxi Medical University. Informed consent was obtained from all subjects.
Epidemiological survey. Epidemiological data including demographics, socioeconomic status, and lifestyle were collected with standardized questionnaires. Height, weight, and waist circumference were measured. Sitting blood pressure was measured three times by a well trained physician with the use of a mercury sphygmomanometer after the subjects had a 5-min rest, and the average of the three measurements was used for the level of blood pressure. Systolic blood pressure (SBP) was determined by the first Korotkoff sound, and diastolic blood pressure (DBP) by the fifth Korotkoff sound. Pulse pressure (PP) was calculated as SBP minus DBP.
Measurements of lipids and apolipoproteins.
Venous blood samples were obtained from all subjects after at least 12 h of fasting. The levels of serum TC, triglyceride (TG), HDL-C, and low-density lipoprotein cholesterol (LDL-C) in samples were determined by enzymatic methods. Serum apolipoprotein (Apo) A1 and ApoB levels were detected by the immunoturbidimetric immunoassay.
Genotyping. Genomic DNA was extracted from the peripheral blood leukocytes by the phenol-chloroform method. Genotyping of ATP-binding cassette transporter A1 (ABCA-1) V825I (rs2066715), acyl-CoA:cholesterol acyltransferase-1 (ACAT-1) rs1044925, low-density lipoprotein receptor (LDL-R) AvaII, hepatic lipase gene (LIPC) -250G>A (rs2070895), endothelial lipase gene (LIPG) 584C>T (rs2000813), methylenetetrahydrofolate reductase (MTHFR) 677C>T (rs1801133), proprotein convertase subtilisin-like kexin type 9 (PCSK9) E670G (rs505151), peroxisome proliferator-activated receptor delta (PPARD) +294T>C (rs2016520) and Scavenger receptor class B type 1 (SCARB1) rs5888 was performed using PCR and restriction fragment length polymorphism. 10 The thermocycling protocol, the approach to electrophoresis, and the procedures for quality control, and the associations of these single-nucleotide polymorphisms and serum lipid levels have been described previously by our reseach group. 10 Diagnostic criteria. Hypertension was defined as an average systolic pressure of 140 mm Hg or greater and/or an average diastolic pressure of 90 mm Hg or greater. 9 Metabolic syndrome was defined based on the updated National Cholesterol Education Program Adult Treatment Panel III criteria for Asian-Americans, 11 including at least three of the following components: (i) waist circumference ≥90 cm in men or ≥80 cm in women; (ii) TG ≥1.7 mmol/l; (iii) HDL-C <1.03 mmol/l in men, or <1.30 mmol/l in women; (iv) blood pressure ≥130/85 mm Hg, or current use of antihypertensive medications; and (v) fasting plasma glucose ≥5.6 mmol/l.
Statistical analysis.
The data are presented as mean ± s.d. or percentage. All statistical analyses were done with the statistical software package SPSS 13.0 (SPSS Inc., Chicago, IL). χ 2 -tests were be used to compare the differences in percentages and to assess Hardy-Weinberg expectations, whereas analysis of covariance were used to compare the differences in various continuous variables between respective comparison groups. The age, education level, physical activity, body mass index (BMI), waist circumference, alcohol consumption, cigarette smoking, and hyperlipidemia were adjusted for the statistical analyses. All significant associations were corrected for multiple testing by applying a Bonferroni correction. The allelic and genotypic frequencies were calculated from the observed genotypic counts. In order to evaluate the association of genotypes (ABCA-1 V825I: GG = 1, GA = 2, AA = 3; ACAT-1 rs1044925: AA = 1, AC = 2, CC = 3; LDL-R AvaII: A-A-= 1, A-A+ = 2, A+A+ = 3; LIPC -250G>A: GG = 1, GA = 2, AA = 3; LIPG 584C>T: CC = 1, CT = 2, TT = 3; MTHFR 677C>T: CC = 1, CT = 2, TT = 3; PCSK9 E670G: AA = 1, AG = 2; PPARD +294T>C: TT = 1, TC = 2, CC = 3; SCARB1 rs5888: CC = 1, CT = 2, TT = 3) or alleles (the minor allele noncarrier = 1, the minor allele carrier = 2) and blood pressure levels, multiple linear regression analysis with stepwise modeling was also performed in the normotensives, hypertensives, males and females; respectively. results general characteristics between normotensives and hypertensives according to sex
As shown in Table 1 , the levels of education, height, weight, HDL-C, ApoA1; the ratio of ApoA1 to ApoB; the percentages of subjects who consumed alcohol and smoked cigarettes in normotensives were higher in males than in females (P < 0.05-0.001). 12 The levels of education, height, waist circumference, TG, ApoA1; the ratio of ApoA1 to ApoB; the percentages of subjects who consumed alcohol and smoked cigarettes in hypertensives were higher but the levels of BMI, LDL-C, and ApoB were lower in males than in females (P < 0.05-0.001).
The levels of waist circumference, SBP, DBP, PP, TC, and TG in males were higher but the levels of education and the percentages of subjects who smoked cigarettes were lower in hypertensives than in normotensives (P < 0.05-0.001). The levels of weight, BMI, SBP, DBP, PP, TC, LDL-C, and ApoB in females were higher but the levels of education were lower in hypertensives than in normotensives (P < 0.05-0.001).
genotypic frequencies between normotensives and hypertensives according to sex
The genotypic distribution of nine single-nucleotide polymorphisms was consistent with the Hardy-Weinberg equilibrium. The genotypic frequencies of LDL-R and SCARB1 in normotensives and ABCA-1, ACAT-1, LDL-R, LIPC, and MTHFR in hypertensives were different between males and females (P < 0.05-0.001). The genotypic frequencies of ABCA-1, ACAT-1, LDL-R, LIPC, MTHFR, PPARD, and SCARB1 in males and ABCA-1, LDL-R, LIPC, LIPG, and MTHFR in females were different between normotensives and hypertensives (P < 0.05-0.001). The GG homozygous of the PCSK9 E670G was not detected in our study population ( Table 2 ).
genotypes and blood pressure levels between normotensives and hypertensives according to sex
The association of genotypes and blood pressure levels is shown in Table 3 . SBP levels in male hypertensives were different among the LIPC, LIPG, PCSK9, and SCARB1 genotypes (P < 0.05-0.01); and DBP levels were different among the ABCA-1, LDL-R, LIPC, LIPG, MTHFR, PCSK9, and PPARD genotypes (P < 0.05-0.001). SBP levels in female hypertensives were different among the LIPC, MTHFR, PCSK9, and PPARD genotypes (P < 0.05-0.01); and DBP levels were different among ABCA-1, ACAT-1, MTHFR, PCSK9, PPARD, and SCARB1 genotypes (P < 0.05-0.001). The results of multiple linear regression analysis between genotypes or alleles and blood pressure levels are shown in Table 4 . For the normotensives, the levels of SBP in males were associated with the genotypes of PPARD (P < 0.05) and the alleles of ABCA-1 and PPARD (P < 0.05 for each); the levels of PP in females were associated with the genotypes and alleles of PCSK9 (P < 0.05 for each). SBP in male hypertensives was correlated with LIPC and PPARD genotypes and alleles (P < 0.05-0.01); and DBP was correlated with ABCA-1, ACAT-1, LIPC, PCSK9, PPARD, and SCARB1 genotypes and alleles (P < 0.05-0.001), and LDL-R and MTHFR genotypes (P < 0.05 for each). SBP in female hypertensives was correlated with LIPC, LIPG, MTHFR, and PPARD genotypes and alleles (P < 0.05-0.001); and DBP was correlated with MTHFR and PCSK9 genotypes and alleles (P < 0.05-0.001), ABCA-1 genotypes (P < 0.05), and PPARD alleles (P < 0.05).
discussion
In the present study, we showed that the genotypic frequencies of LDL-R and SCARB1 in normotensives; and ABCA-1, ACAT-1, LDL-R, LIPC, and MTHFR in hypertensives were different between males and females. On the contrary, the genotypic frequencies of ABCA-1, ACAT-1, LDL-R, LIPC, MTHFR, PPARD, and SCARB1 in males; and ABCA-1, LDL-R, LIPC, LIPG, and MTHFR in females were different between normotensives and hypertensives. SBP, DBP and PP were also associated with these genotypes or alleles correspondingly. These results indicate that several lipid-related gene polymorphisms may involve in the development of hypertension between men and women. Although genetic variants in some lipid-related genes have been associated with risk of hypertension in some studies, to our knowledge, the association between ABCA-1 V825I, ACAT-1 rs1044925, LIPG 584C>T, PCSK9 E670G, and SCARB1 rs5888 polymorphisms and blood pressure levels has not been previously explored. The association of ABCA-1 gene polymorphism and blood pressure levels is not well known. Xu et al. 13 reported that the expression of ABCA-1 was significantly decreased in the newly diagnosed untreated hypertensives compared with that in healthy controls. The levels of ABCA-1 were negatively associated with blood pressure levels, and the reduction of ABCA-1 could be reversed by antihypertensive therapy. Yamada et al. 14 found that the -14C→T polymorphism of ABCA-1 were significantly associated with the prevalence of hypertension in a Japanese population. SBP and DBP differed significantly among genotypes for the -14C→T polymorphism of ABCA-1, with the variant T allele, respectively, being related to increased blood pressure.
Several previous studies showed that genetic variation at LDL-R is associated with essential hypertension. [15] [16] [17] [18] [19] Genetic polymorphism at LDL-R (19p13.2, ApaLI and HincII) has been described to be associated with obesity in Caucasian essential hypertensives. [15] [16] [17] A common mutation of LDL-R C1773T was also associated with essential hypertension among Japanese. 18 The C1773 allele was significantly more frequent among hypertensives than normotensives. Liljedahl et al. 19 found that the C16730T polymorphism in the LDL-R gene predicted the change in SBP in the atenolol group with an average reduction of 14 mm Hg in the individuals carrying the C allele. In a previous study, however, Liu et al. 20 found that there were no differences in the genotypic and allelic frequencies of the LDL-R AvaII between normotensives and essential hypertensives in Shanghai.
Bernard et al. 21 showed that the TT homozygosity of the LIPC -514 C>T polymorphism decreased the risk of gestational hypertension. LIPC V95M polymorphism was also significantly associated with both blood pressure variation and hypertension. 22 Shimokawa et al. 23 found that the expression of endothelial lipase is increased in rat models of hypertension. Endothelial lipase might have a role in the local pathophysiology of vascular diseases. Recently, Yamaguchi et al. 24 reported that the 584C→T polymorphism of LIPG was significantly associated with atherothrombotic cerebral infarction in women or men or in individuals with or without hypertension, hypercholesterolemia, or diabetes mellitus. The LIPG 584C>T polymorphism was also associated with acute myocardial infarction independently of HDL-C levels. 25 The association of MTHFR 677C>T polymorphisms and blood pressure levels in humans is inconsistent. [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] Rodríguez-Esparragón et al. 26 found that TT genotype of MTHFR C677T was associated with an increased risk of hypertension in males. In a previous meta-analysis, Kosmas et al. 27 showed that the MTHFR C677T polymorphism was consistently associated with hypertension in pregnancy. The T allele may increase the risk of severe diastolic hypertension during pregnancy. Jiang et al. 28, 29 found that the MTHFR C667T polymorphism and MTHFR 677C-1298C haplotype modulated baseline DBP and DBP responsiveness by short-term treatment of benazepril in Chinese essential hypertensives. However, baseline SBP and SBP response did not significantly associate with MTHFR C677T polymorphism. In a recent meta-analysis, Qian et al. 30 combined 26 English and Chinese studies in Caucasian and Asian populations published up to November 2006 to give a new picture of the role of the MTHFR C677T polymorphism. Evidence of significant association was detected between C677T polymorphism and hypertension in both populations. Additionally, the significant association between C677T polymorphism and hypertension/hypertension-in-pregnancy suggested that this polymorphism was one independent risk factor of hypertension. Markan et al. 31 found that the patients carrying MTHFR 677T allele were at increased risk of hypertension. The frequency of co-occurrence of MTHFR 677CT/1298CC genotypes was significantly higher in the patients compared to controls and was associated with increased risk of hypertension. Marinho et al. 32 showed that the genotypic distribution of MTHFR differs significantly between controls and hypertensives with a greater prevalence of CT genotypes. Ilhan et al. 33 showed that the MTHFR 677C allele was significantly more frequent in controls compared with patients with essential hypertension, and CC genotype was more frequent in controls compared to patients with essential hypertension. MTHFR C677T polymorphism is an independent risk factor for essential hypertension. In 206 untreated patients with primary hypertension, however, Ravera et al. 34 showed that there were no differences as for blood pressure levels on the basis of MTHFR genotype. Lwin et al. 35 found that the MTHFR mutation was not independently associated with prevalence of hypertension or blood pressure levels. In 134 healthy pregnant women, 266 pregnant with non-proteinuric hypertension and 184 patients with preeclampsia, Stiefel et al. 36 also found that there were no significant differences detected in genotype or allele distribution of the MTHFR C677T polymorphism.
Cui et al. 37 reported that serum PCSK9 levels ranged from 12.85 to 222.50 ng/ml with a mean concentration of 69.35 ng/ ml. It was slightly higher in women than in men. Compared to premenopausal women, postmenopausal women had significantly higher PCSK9 levels. There was a significant positive association between serum PCSK9 levels and SBP in men. In women, there was a positive correlation between PCSK9 levels and DBP. These results indicate that the serum PCSK9 level may be a biomarker of hypertension.
Gao et al. 38 reported that PPAR-γ2 gene polymorphism is associated with hypertension. The frequency of the Ala allele was lower in patients with hypertension (1.3%) than in controls (3.6%), suggesting that the Ala allele is involved in genetic susceptibility to hypertension in the Han population of Inner Mongolia. Ostgren et al. 39 showed that the Pro12Ala polymorphism in the PPAR-γ is associated with blood pressure in subjects with type 2 diabetes. The subjects with Pro/Ala (24%) or Ala/Ala (2%) had lower DBP when adjusted for age and gender compared with Pro/Pro subjects (74%). This association was restricted to men, who also had a borderline significant difference in SBP. In men the difference in DBP remained after adjustment for age, BMI, serum TG, insulin and haemoglobin A (1c). A subanalysis of normotensive men confirmed the difference associated with the Pro12Ala polymorphism in DBP. Yan et al. 40 reported that the relationship between PPARD +294T>C gene polymorphism and lipid profile, obesity and left ventricular hypertrophy in 300 patients with metabolic syndrome, 174 patients with essential hypertension, and 143 patients with type 2 diabetes mellitus. But the frequencies of the PPARD +294T>C genotypes were not different among three groups.
The present study has some shortcomings. Firstly, we did not investigate the possible influence of the postmenopausal state on blood pressure levels. There were 277 females aged ≥40 years in normotensive group, and 233 women aged ≥40 years in hypertensive group. Secondly, we did not exclude the subjects with metabolic syndrome in the present study. Many of the relations between plasma lipids and blood pressure are explainable through this condition. According to the updated National Cholesterol Education Program Adult Treatment Panel III criteria for Asian-Americans, 11 there were 12 subjects in normotensive group and 18 individuals in hypertensive group with three components of metabolic syndrome. Thirdly, the levels of education, height, ApoA1; the ratio of ApoA1 to ApoB; the percentages of subjects who consumed alcohol and smoked cigarettes in both normotensives and hypertensives were higher in males than in females. Although age, education level, physical activity, BMI, waist circumference, alcohol consumption, cigarette smoking, and hyperlipidemia have been adjusted for the statistical analysis, we could not completely eliminate the potential influence of these factors on blood pressure levels. Finally, it is well known that blood pressure levels are modulated by multiple environmental and genetic factors, and their interactions. Although we have detected the association of nine lipid-related gene polymorphisms and blood pressure variation in this study, there are still many unmeasured environmental and genetic factors 8 and their interactions. Thus, the genetic determination of blood pressure and hypertension traits remain to be investigated.
Several lipid-related gene polymorphisms are found to be associated with blood pressure levels in the Guangxi Bai Ku Yao population. Sex differences in the association of these genetic polymorphisms and blood pressure variation were also obversed. The observed association between these genetic polymorphisms and hypertension in this isolated ethnic subgroup may also be the major characteristics of this condition in the other ethnic groups, especially in the minorities. However, large studies of populations with different ethnic origins are required to confirm these observations.
